Official: Africa needs COVID-19 vaccine for 60% in 2-3 years
Africa’s top public health official says 60% of the continent’s population needs to be vaccinated against the coronavirus in the next two to three years
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Africa’s top public health official says 60% of the continent’s population needs to be vaccinated against the coronavirus in the next two to three years.
The director of the Africa Centers for Disease Control and Prevention, John Nkengasong, told reporters on Thursday that if it takes four to five years, “the virus will be endemic in our communities.”
African health officials are taking heart in vaccine progress, but concerns are growing that the continent of 1.3 billion people will be near the end of the line in obtaining doses. Nkengasong isn’t sure whether vaccines will be available in Africa before the second quarter of next year.
But he is pushing back against fears and misinformation around COVID-19 vaccines, saying that “if I had my way today to take a flight to the U.K. and get that vaccine, I would be doing it right now.” He was referring to Britain's go-ahead for emergency use of the vaccine developed by American drugmaker Pfizer and Germany’s BioNTech.
Nkengasong says the 60% vaccination target is needed to achieve herd immunity in Africa’s 54 countries.
He stressed the challenges ahead, saying “the continent as a whole has never vaccinated 200 million people in one year,” a reference to the goal of reaching about 20% of the population by the end of 2021.
Nkengasong also vowed that “no sub-standard vaccines will be in use in Africa.” The continent can't afford to do country-by-country regulatory approval, he said, estimating it would take five years or more. Instead, the Africa CDC is offering a platform where national regulatory bodies can agree on a mechanism to approve any vaccines that come to the continent, he said.
“We are stronger when we are together,” he added, as a handful of African countries have started looking into obtaining vaccine doses for their own citizens outside the global initiative aiming at equitable vaccine distribution known as COVAX. “If we go in a dispersed way as a continent, then our overall strategy will suffer.”
The African continent now has close to 2.2 million confirmed virus cases, or about 3.5% of the global total, as health officials warn of signs of a second surge in some countries.
“The next two months are critical because the continent as a whole will go into the holiday season,” meaning more travel from urban to rural areas, Nkengasong said. “My fear is that we will peak, probably have the same peak as in July or August, in the coming months.”
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.